2.17
price up icon6.90%   0.14
after-market アフターアワーズ: 2.11 -0.06 -2.76%
loading

Milestone Pharmaceuticals Inc (MIST) 最新ニュース

pulisher
12:16 PM

Milestone Pharmaceuticals Eyes FDA Approval for CARDAMYST - TipRanks

12:16 PM
pulisher
Mar 13, 2025

Milestone Pharmaceuticals Awaits FDA Decision on CARDAMYST, Prepares for Mid-2025 Launch - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Milestone Pharmaceuticals: Q4 Earnings Snapshot - CTPost

Mar 13, 2025
pulisher
Mar 13, 2025

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

Milestone Pharmaceuticals Inc Full Year Loss Decreases, But Misses Estimates - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Milestone Pharmaceuticals Inc. SEC 10-K Report - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

Milestone Pharmaceuticals (MIST) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 13, 2025
pulisher
Mar 09, 2025

Sun Pharma to acquire Checkpoint Therapeutics for $355 million in cash and milestone payments - CNBCTV18

Mar 09, 2025
pulisher
Mar 06, 2025

Best Biotech Stocks to Buy in 2025 - The Motley Fool

Mar 06, 2025
pulisher
Mar 04, 2025

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Milestone Pharmaceuticals Awards 94,000 Stock OptionsWhat This Means for Shareholder Value - StockTitan

Mar 04, 2025
pulisher
Mar 03, 2025

Milestone Pharmaceuticals’ (MIST) “Buy” Rating Reiterated at HC Wainwright - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Can Milestone Pharma's Trial Data Of Etripamil Nasal Spray In AFib-RVR Win Investors' Hearts? - RTTNews

Mar 02, 2025
pulisher
Feb 28, 2025

US FDA’s March Approval Candidates Take Aim At Established Markets - Citeline News & Insights

Feb 28, 2025
pulisher
Feb 27, 2025

Milestone® Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference - The Manila Times

Feb 27, 2025
pulisher
Feb 27, 2025

When Can Investors Hear Milestone Pharma's Next Strategic Update? Key Conference Date Revealed - StockTitan

Feb 27, 2025
pulisher
Feb 25, 2025

Milestone Pharmaceuticals Prepares for CARDAMYST Launch - TipRanks

Feb 25, 2025
pulisher
Feb 25, 2025

NLS Pharmaceutics and Partners Achieve Milestone in Diabetes Treatment Development - MSN

Feb 25, 2025
pulisher
Feb 19, 2025

Milestone Pharmaceuticals Gets Notice of Allowance for US Patent on Etripamil Nasal Spray - Marketscreener.com

Feb 19, 2025
pulisher
Feb 19, 2025

Milestone Pharmaceuticals secures key patent for CARDAMYST By Investing.com - Investing.com South Africa

Feb 19, 2025
pulisher
Feb 19, 2025

Milestone Pharmaceuticals secures key patent for CARDAMYST - Investing.com India

Feb 19, 2025
pulisher
Feb 19, 2025

Milestone® Pharmaceuticals Notice of Allowance on New U.S. Patent for Etripamil - The Manila Times

Feb 19, 2025
pulisher
Feb 19, 2025

Milestone receives notice of allawance from USPTO on etripamil nasal spray - TipRanks

Feb 19, 2025
pulisher
Feb 15, 2025

Short Interest in Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Declines By 27.9% - MarketBeat

Feb 15, 2025
pulisher
Feb 13, 2025

Adversity is less terrifying than hope: Milestone Pharmaceuticals Inc (MIST) - SETE News

Feb 13, 2025
pulisher
Feb 13, 2025

AGIOS PHARMACEUTICALS, INC. SEC 10-K Report - TradingView

Feb 13, 2025
pulisher
Feb 12, 2025

MISTMilestone Pharmaceuticals Latest Stock News & Market Updates - StockTitan

Feb 12, 2025
pulisher
Feb 12, 2025

Neuphoria Therapeutics to receive $15M milestone payment from Merck - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck - Yahoo Finance

Feb 12, 2025
pulisher
Feb 11, 2025

Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025 - The Manila Times

Feb 11, 2025
pulisher
Feb 11, 2025

Milestone's CARDAMYST Launch Roadmap: Key Details Coming for $1B PSVT Market Opportunity - StockTitan

Feb 11, 2025
pulisher
Feb 11, 2025

Retail investors who hold 57% of Milestone Pharmaceuticals Inc. (NASDAQ:MIST) gained 14%, institutions profited as well - Simply Wall St

Feb 11, 2025
pulisher
Feb 10, 2025

Milestone Pharmaceuticals Inc (MIST) may enjoy gains as insiders got busy in the recent days - Knox Daily

Feb 10, 2025
pulisher
Feb 07, 2025

Milestone Pharmaceuticals Inc (MIST) Stock: A Closer Look at the Analyst Ratings - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Milestone Pharmaceuticals Inc (MIST) Stock: A Year of Highs and Lows - The InvestChronicle

Feb 07, 2025
pulisher
Feb 07, 2025

Conduit's AI-Powered Drug Development Takes Major Leap: Real-Time Trial Dashboard Unveiled - StockTitan

Feb 07, 2025
pulisher
Feb 05, 2025

BlackRock, Inc. Reduces Stake in Milestone Pharmaceuticals Inc - GuruFocus.com

Feb 05, 2025
pulisher
Feb 04, 2025

What was Milestone Pharmaceuticals Inc (MIST)’s performance in the last session? - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Insider’s View: Deciphering Fangdd Network Group Ltd (DUO)’s Financial Health Through Ratios - The Dwinnex

Feb 04, 2025
pulisher
Feb 03, 2025

Loss-Making Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Expected To Breakeven In The Medium-Term - Yahoo Finance

Feb 03, 2025
pulisher
Feb 01, 2025

What is HC Wainwright's Forecast for MIST FY2029 Earnings? - MarketBeat

Feb 01, 2025
pulisher
Feb 01, 2025

HC Wainwright Analysts Decrease Earnings Estimates for MIST - MarketBeat

Feb 01, 2025
pulisher
Jan 31, 2025

More Heart, Less Skin: US FDA’s 2025 Novel Approvals Should Reflect Pipeline Shifts - Citeline News & Insights

Jan 31, 2025
pulisher
Jan 30, 2025

Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research - BioPharma Dive

Jan 30, 2025
pulisher
Jan 30, 2025

HC Wainwright Has Pessimistic Outlook of MIST Q1 Earnings - Defense World

Jan 30, 2025
pulisher
Jan 29, 2025

Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone - PR Newswire

Jan 29, 2025
pulisher
Jan 29, 2025

Milestone Pharma Faces FDA Decision In MarchWill It Mean Heartbreak Or Happiness For Investors? - RTTNews

Jan 29, 2025
pulisher
Jan 29, 2025

FY2029 Earnings Estimate for MIST Issued By HC Wainwright - Defense World

Jan 29, 2025
pulisher
Jan 29, 2025

Jaguar Health Provides Corporate Update and Outlines 2022 Milestones - ACCESS Newswire

Jan 29, 2025
pulisher
Jan 28, 2025

Milestone gears up for CARDAMYST launch in 2025 By Investing.com - Investing.com Australia

Jan 28, 2025
pulisher
Jan 28, 2025

Milestone gears up for CARDAMYST launch in 2025 - Investing.com

Jan 28, 2025
pulisher
Jan 28, 2025

Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC - The Manila Times

Jan 28, 2025
pulisher
Jan 28, 2025

Game-Changing Heart Treatment Could Hit Market in 2025: Inside Milestone's Launch Strategy - StockTitan

Jan 28, 2025
pulisher
Jan 28, 2025

Milestone Pharmaceuticals (NASDAQ:MIST) Receives “Buy” Rating from HC Wainwright - Defense World

Jan 28, 2025
$307.24
price up icon 0.61%
$76.55
price up icon 1.97%
$32.77
price up icon 0.28%
$20.79
price up icon 8.34%
$99.47
price up icon 2.06%
biotechnology ONC
$259.19
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):